Nautilus Biotechnology (NAUT) Profit After Tax (2020 - 2026)

Nautilus Biotechnology has disclosed Profit After Tax across 7 years of filings, most recently posting -$14.7 million for Q1 2026.

• Profit After Tax for Q1 2026 came in at -$14.7 million, up 11.53% year-over-year; the trailing twelve-month figure through Mar 2026 was -$57.1 million (up 16.86% YoY), and the FY2025 annual result was -$59.0 million, up 16.64% from the prior year.
• Profit After Tax came in at -$14.7 million for Q1 2026 at Nautilus Biotechnology, down from -$13.8 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$13.4 million in Q4 2022 to a low of -$18.7 million in Q1 2024.
• The 5-year median for Profit After Tax is -$15.8 million (2022), against an average of -$15.7 million.
• Across the five-year window, Profit After Tax slumped 87.45% in 2022 and gained 21.67% in 2025, its largest moves.
• Nautilus Biotechnology's Profit After Tax stood at -$13.4 million in 2022, then fell by 26.96% to -$17.0 million in 2023, then slipped by 3.35% to -$17.6 million in 2024, then rose by 21.67% to -$13.8 million in 2025, then decreased by 6.65% to -$14.7 million in 2026.
• The last three Profit After Tax figures came in at -$14.7 million (Q1 2026), -$13.8 million (Q4 2025), and -$13.6 million (Q3 2025), per Business Quant data.